Caricamento...
Proteasome inhibitors suppress the protein expression of mutant p53
Tumor suppressor p53 is one of the most frequently mutated genes in cancer, with almost 50% of all types of cancer expressing a mutant form of p53. p53 transactivates the expression of its primary negative regulator, HDM2. HDM2 is a ubiquitin ligase, which initiates the proteasomal degradation of p5...
Salvato in:
| Pubblicato in: | Cell Cycle |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4613555/ https://ncbi.nlm.nih.gov/pubmed/25485499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/15384101.2014.950132 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|